We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Studies Demonstrate How AI Can Personalize and Optimize Breast Cancer Detection

By MedImaging International staff writers
Posted on 10 Mar 2023
Print article
Image: New studies demonstrate important role of AI in breast cancer risk, detection and prevention (Photo courtesy of Volpara)
Image: New studies demonstrate important role of AI in breast cancer risk, detection and prevention (Photo courtesy of Volpara)

New studies have demonstrated the important role played by artificial intelligence (AI) in objective breast density assessment, cancer risk assessment, and mammography quality evaluation to personalize and optimize breast cancer detection.

The latest studies presented by Volpara Health (Wellington, New Zealand) found that combining the AI computer-aided-detection system Transpara with Volpara volumetric density assessment led to better screening efficacy for women with dense breast tissue as compared to a traditional double read by radiologists. The studies also found that using Tyrer-Cuzick with volumetric density assessment from Volpara Scorecard to identify and triage intermediate and high-risk patients for ultrasound improved the cancer detection rate as compared to traditional biennial mammography. In addition, the studies found that using Volpara Analytics software to evaluate radiographer performance improved the quality, irrespective of the experience level.

The research included personalized screening and optimization studies, such as the DENSE1, TOMMY2, and To-Be3 trials, and the PROCAS I/II4 and KARMA5 studies. A prime example, the DENSE trial, utilized Volpara's TruDensity volumetric density product to identify women with extremely dense breasts in their randomized controlled trial of supplemental MRI that helped shape the latest screening recommendations by the European Society of Breast Imaging. The recommendations suggest that density must be reported to all women receiving mammography and women aged 50 to 70 with extremely dense breasts must undertake MRI.

"Increasing our understanding of breast cancer risk, detection and prevention is essential to ensuring every patient is given the right care at the right time," said Teri Thomas, Volpara CEO.

Related Links:
Volpara Health 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
MRI System
uMR 588
Compact C-Arm with FPD
Arcovis DRF-C R21
New
DR Flat Panel Detector
1500L

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.